Human recombinant [C22A] FK506-binding protein amide hydrogen exchange rates from mass spectrometry match and extend those from NMR.

Hydrogen/deuterium exchange behavior of human recombinant [C22A] FK506 binding protein (C22A FKBP) has been determined by protein fragmentation, combined with electrospray Fourier transform ion cyclotron resonance mass spectrometry (MS). After a specified period of H/D exchange in solution, C22A FKBP was digested by pepsin under slow exchange conditions (pH 2.4, 0 degree C), and then subjected to on-line HPLC/MS for deuterium analysis of each proteolytic peptide. The hydrogen exchange rate of each individual amide hydrogen was then determined independently by heteronuclear two-dimensional NMR on 15N-enriched C22A FKBP. A maximum entropy method (MEM) algorithm makes it possible to derive the distributions of hydrogen exchange rate constants from the MS-determined deuterium exchange-in curves in either the holoprotein or its proteolytic segments. The MEM-derived rate constant distributions of C22A FKBP and different segments of C22A FKBP are compared to the rate constants determined by NMR for individual amide protons. The rate constant distributions determined by both methods are consistent and complementary, thereby validating protein fragmentation/mass spectrometry as a reliable measure of hydrogen exchange in proteins.     

The affinity of human RANK binding to its ligand RANKL

Receptor activator of nuclear factor-kappa B (RANK) and its ligand, RANKL play critical roles in bone re-modeling, immune function, vascular disease and mammary gland development. To study the interaction of RANK and RANKL, we have expressed both extracellular domain of RANK and ectodomain of RANKL using Escherichia coli expression system. RANK was expressed as an inclusion body first which properly refolded later, while RANKL was initially produced as a GST fusion protein, after which the GST was removed by enzyme digestion. Soluble RANK existed as a monomer while RANKL was seen as a trimer in solution, demonstrated by gel filtration chromatography and cross-linking experiment. The recombinant RANK and RANKL could bind to each other and the binding affinity of RANKL for RANK was measured with surface plasmon resonance technology and K_D value is about 1.09 × 10⁻¹⁰ M.     

利用葡萄糖废母液生产酒精的研究

选育出两株利用葡萄糖废母液生产酒精的菌株S_(995)和S_8。S_(095)用于70％母液和30％糖蜜混合连续酒精发酵,醪液中酒精份平均可达10.1％。S_8用于50％、70％母液和50％、30％玉米糖化醪混合生产酒精,醪液中酒精份可达12.37％(实验室数据)和10％(实际生产数据)。     

重组α-银环蛇毒素的纯化及活性分析

以表达重组α-银环蛇毒素的高效表达菌株BL21(PDZ04)为材料,研究重组α-银环蛇毒素(α-bungarotoxin,α-BgTx)的分离纯化。采取亲和色谱和离子交换色谱的方法都得到了重组α-银环蛇毒素的纯品。参考文献报道的方法从天然的银环蛇毒干粉中分离纯化得到了天然α-银环蛇毒素的纯品。然后以天然α-银环蛇毒素为对照来检测重组α-银环蛇毒素的抗原性和毒性。ELISA结果显示其具有与天然α-银环蛇毒素相似的抗原性,以小鼠为动物模型,纯化的重组α-银环蛇毒素与天然α-银环蛇毒素相比,其腹腔注射的LD50也基本一致,约为0.22μg/g。结果表明利用基因工程的方法生产蛇神经毒素是可行的。     

成人腹泻轮状病毒的提纯及其高价免疫血清的制备

本文采用交叉免疫电泳技术,首先提纯了成人腹泻轮状病毒(Adult DiarrhoeaRotavirus简称:ADRV),并经电镜确认,用作免疫抗原,首次制备了高价兔与豚鼠抗ADRV血清和小鼠抗ADRV腹水,其特异性经交叉免疫电泳和对流免疫电泳鉴定,其效价经酶联免疫吸附试验(ELISA)检测均在1:2,000以上。     

大豆花叶病毒种子传毒率测定方法的比较

用苗期症状观察和酶联免疫吸附试验(ELISA)两种方法检查了大豆种子内的大豆花叶病毒(sMV)的传毒率及带毒率,并对两种方法所得的结果进行了比较。带毒大豆种子产生的病苗,其症状主要有花叶、卷叶、叶脉束状、叶脉坏死、凸斑和单叶扭曲等类型。苗期症状观察得到的种子传毒率,与用ELISA法检查去种皮大豆种子的带毒率高度吻合,相关系数r=0.92(n=31),说明此两种方法检查种子传(带)毒率具有相同的生物学和病理学意义。 本文提出了种子“群体病毒浓度”的概念。“群体病毒浓度”=群体内病毒总量/群体内种子总数。38个处理组合和3,591粒种子逐粒用ELISA法检查表明,“群体病毒浓度”与该群体的种子传毒率呈正相关,r=0.93(n=38)。将种子群体作为一个整体用ELISA法检查的结果也证明,“群体病毒浓度”与种子传毒率呈直线相关。因此认为可以用ELISA法对种子群体直接进行测定来估计种子的传毒率。     

Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction

MDM2 is an important negative regulator of the tumor suppressor protein p53 which regulates the expression of many genes including MDM2. The delicate balance of this autoregulatory loop is crucial for the maintenance of the genome and control of the cell cycle and apoptosis. MDM2 hyperactivity, due to amplification/overexpression or mutational inactivation of the ARF locus, inhibits the function of wild-type p53 and can lead to the development of a wide variety of cancers. Thus, the development of anti-MDM2 therapies may restore normal p53 function in tumor cells and induce growth suppression and apoptosis. We report here a novel high-throughput fluorescence polarization binding assay and its application in rank ordering small-molecule inhibitors that block the binding of MDM2 to a p53-derived fluorescent peptide.